Bipolar Disorder - ECT Follow-up Study
Follow-up Study of Patients with Bipolar Disorder Treated with ECT
Protocol ID
04.08.132T
Protocol Description
The purpose of this research study is to follow patients treated with electroconvulsive therapy (ECT) for a depressive episode of bipolar illness. We are interested in understanding what happens to these patients after the treatment, if they remain well or if they require further treatment.
Eligibility Criteria
Patients treated with electroconvulsive therapy (ECT) for a depressive episode of bipolar illness
Primary Investigator(s)
- Rafael Braga, MD
Contact Information
Last Update
April 2, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Systemic Lupus Erythematosus - Classification and Criteria (ARoSE) (07.08.049)
- Systemic Lupus Registry (07-053)
- Systemic Lupus Erythematosus - Vitamin D3 Study (08-109)
- Systemic Lupus Erythematosus - Gene Study (SAGE) (08-205)
- Pulmonary Artery Hypertension - Biomarker Study (07-030)
- Drug Use, Depression and Anxiety - Qi Gong Study (06-081)
- Bipolar Disorder - Neurocognitive Study (04.04.105)
- Cystic Fibrosis Patient Registry (02.08.156)
- Systemic Lupus Erythematosus - Pediatric Atherosclerosis Prevention Study (03.10.074T)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- Rituximab in SLE: Effects of Immune Reconstitution on Treatment Response (06.08.094T)
- Cystic Fibrosis Patient Registry (Pediatrics) (02.08.171)
- Acute Coronary Syndrome Study (06-099T)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Clinical Correlates of Memory Impairment (03.08.160)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Normal Control Registry for Current and Future Research (04-007/G)
- Research Recruitment Screening Database (05.08.167T)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Lupus Nephritis - Clinical Trial (08-197)
- Systemic Lupus Erythematosus - Antibody Study (07-081)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Bipolar Disorder - Clinical Trial (08-001)
- Schizophrenia - Relapse Prevention Study (05.04.063)
- Depression - COMED Study (07.04.133)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Bipolar Susceptibility Study (08-132)
- Brain Networks in Parkinson's Disease (04-113T)
- Schizophrenia - Clinical Trial (05.04.086)
- National Marrow Donor Program's Research Sample Repository (03.10.116)
- National Marrow Donor Program Research Database (03.10.117)
- Smoking Cessation - Lozenge vs. Patch (06-030)
- Opiod Analgesic Depression - Clinical Trial (06.04.109T)
- Tissue Banking - Laryngeal and Tracheal Disease (03.02.080)
- Bipolar Disorder - White Matter Integrity Study (02.08.187)
- Stenting and Angioplasty Post-Marketing Study (06-02-281)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- CF - Expanded Access Study (07-02-201)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Focal Segmental Glomerulosclerosis Study (07-10-238)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- HIV - Clinical Trial (08-02-160)
- Asthma - Clinical Trial (08-02-188)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- Cystitis-Painful Bladder Study - (08-269)
- Pelvic Pain Study - (08-274)
- Prediction of Relapse in Schizophrenia - (08-278)
- Schizophrenia - Clinical Trial (08-296)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-112)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-133)
- Cystic Fibrosis - Clinical Trial (09-02-147)
- Cystic Fibrosis - Clinical Trial (09-10-102)
- Systemic Lupus Erythematosus Registry (09-104)
- Bipolar Disorder - Mindfulness Training Study (10-013B)
- Vest Prevention of Early Sudden Death Trial (VEST) and Prediction of ICD Therapies Study (PREDICTS) (09-056)
- Systemic Lupus Erythematosus Study (09-122)
- Genes and Phenotype Study (09-081)
- National Lymphatic Disease and Lymphedema Registry (09-137)
- Prolonging Remission in Depressed Elderly (PRIDE) (09-078)
- White Matter Endophenotypes in Bipolar Disorder (09-222)
- Biomarkers in the Evaluation of Chronic Lung Disease (09-076)
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
-
Mental Health
- Alzheimer's Disease - Endocannabinoid System Study (05.04.140)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Bipolar Disorder
- Clinical Correlates of Memory Impairment (03.08.160)
- Cognitive Aging: Screening and Genetic Associations (07-127)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Dementia - Clinical Trial (08-295)
- Depression
- Ecopipam Treatment of Tourette's Disorder (PSY301, 10-02-226-03)
- Genetic Correlates of Memory Impairment (03.04.169T)
- Genetics and Dimensions of Psychopathology (09-062)
- Genetics of Early Onset Psychiatric Disorders (06-097)
- Genetics of Psychiatric Disorders (04.04.077)
- Healthy Volunteers - Screening for Research Studies (05.04.022T)
- Induced Pluripotent Stem Cells (IPS) and Psychiatric Disorders (09-280)
- Memory Disorders Study (08-219)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Obsessive Compulsive Disorder
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- Psychosis - Early Detection/Prevention Study (07.04.075)
- Psychosis - PET Study (09-037)
- Schizophrenia
- Tourette Syndrome - Genetic Study (08-003)
- Neurosciences
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health